Fewer than 1% of patients with type 1 diabetes achieve normal glycemic control (HbA1c < 5.7%/<39 mmol/mol) and exogenous insulin administration often causes “iatrogenic hyperinsulinemia,” leading to whole-body insulin resistance and increased risk of cardiovascular complications. This evidence concerns the gene INS and hyperinsulinism.